Infection Rate, Mortality and Characteristics of Veterans with Amyotrophic Lateral Sclerosis with COVID-19

Overview

Journal Muscle Nerve

Date 2021 Jul 13

PMID 34255865

Citations 9

Authors

Marinella D Galea

Vincent P Galea

Adam C Eberhart

Huned S Patwa

Ileana Howard

Christina N Fournier

Richard S Bedlack

Affiliations

Soon will be listed here.

Citing Articles

Impact of SARS-CoV-2 infection and COVID-19 pandemic on the morbidity and mortality of amyotrophic lateral sclerosis patients in Valencia, Spain.

Garcia-Casanova P, Perez-Martinez P, Sevilla T, Domenech R, Leon M, Vazquez-Costa J Eur J Neurol. 2024; 31(12):e16465.

PMID: 39240038 PMC: 11554849. DOI: 10.1111/ene.16465.

A Comprehensive Review of Neurodegenerative Manifestations of SARS-CoV-2.

Bedran D, Bedran G, Kote S Vaccines (Basel). 2024; 12(3).

PMID: 38543856 PMC: 10974019. DOI: 10.3390/vaccines12030222.

A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial.

Lombardo F, Spila Alegiani S, Mayer F, Cipriani M, Lo Giudice M, Ludolph A Trials. 2023; 24(1):792.

PMID: 38053196 PMC: 10696667. DOI: 10.1186/s13063-023-07638-w.

Simulation of the mortality after different ex ante (secondary) and ex post (tertiary) triage methods in people with disabilities and pre-existing diseases.

Garber S, Brunner J, Heller A, Marckmann G, Bartenschlager C Anaesthesiologie. 2023; 72(Suppl 1):10-18.

PMID: 37733034 PMC: 10692011. DOI: 10.1007/s00101-023-01336-7.

[Simulation of mortality after different ex-ante and ex-post-triage methods in people with disabilities and comorbidities].

Garber S, Brunner J, Heller A, Marckmann G, Bartenschlager C Anaesthesiologie. 2023; 72(8):555-564.

PMID: 37358616 PMC: 10400691. DOI: 10.1007/s00101-023-01302-3.

References

Esselin F, De La Cruz E, Pageot N, Juntas-Morales R, Alphandery S, Camu W . Increased worsening of amyotrophic lateral sclerosis patients during Covid-19-related lockdown in France. Amyotroph Lateral Scler Frontotemporal Degener. 2021; 22(7-8):505-507. DOI: 10.1080/21678421.2021.1883669. View

Richardson S, Hirsch J, Narasimhan M, Crawford J, McGinn T, Davidson K . Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020; 323(20):2052-2059. PMC: 7177629. DOI: 10.1001/jama.2020.6775. View

van Es M, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp R, Veldink J . Amyotrophic lateral sclerosis. Lancet. 2017; 390(10107):2084-2098. DOI: 10.1016/S0140-6736(17)31287-4. View

Talbot K . Motor neuron disease: the bare essentials. Pract Neurol. 2009; 9(5):303-9. DOI: 10.1136/jnnp.2009.188151. View

Mehta P, Kaye W, Raymond J, Wu R, Larson T, Punjani R . Prevalence of Amyotrophic Lateral Sclerosis - United States, 2014. MMWR Morb Mortal Wkly Rep. 2018; 67(7):216-218. PMC: 5858037. DOI: 10.15585/mmwr.mm6707a3. View